Research

Medisafe is pleased to share the latest results from a University of Sydney study, showing that mobile apps can have a significant impact on those living with coronary heart disease. Following an initial study conducted in 2016 to identify the leading medication management platform, in which Medisafe was found to be the top performing solution,…

MIAMI — June 7, 2018  — Medisafe, the leading medication management platform with almost four and a half million registered users, today released data showing that previously non-adherent HIV patients increase their prescription refills after they start using the company’s mobile app. These results are part of a landmark study conducted by IQVIA, a leading global provider…

Medisafe, the leading medication management platform with over four million registered users, announced today the first wave of results from a novel study, which among other objectives, measures the accuracy of self-reported outcomes (SROs). Medisafe’s study was conducted in partnership with the leading global provider of information, innovative technology solutions and contract research services focused…

Medisafe, the leading medication management platform with almost four and a half million registered users, released data today showing that, on average, hypertensive patients increase their prescription refills by almost 10% after they start using the company’s mobile app. This novel study is being conducted by the leading global provider of information, innovative technology solutions…

Dr. Danny Sands Chief Medical Officer, Medisafe Today, Medisafe shared preliminary results of a study performed by the leading global provider of information, innovative technology solutions and contract research services focused on healthcare data. The purpose was to understand the real impact of Medisafe on users’ medication adherence. It goes without saying that patients not…

Study rationale One in every three U.S. adults, about 78 million Americans, have high blood pressure, the single most important and most common risk factor for cardiovascular disease Only 51% of Americans treated for hypertension are adherent to long-term medication therapy Only 52% have their blood pressure under control The total health and economic costs…

Study rationale Research shows that social support using existing friends or family has been associated with greater medication adherence. Thus, Medisafe conducted a retrospective study evaluating the impact of its Medfriend feature, which provides users with social support through the app. The Medfriend feature enables users to connect to and alert caregivers, family and friends…

In a recent study conducted by the prominent IQVIA Institute for Human Data Science (previously QuintilesIMS), designated Medisafe as the “Top Free & Publically Available App for Medication Management.” The report, entitled “The Growing Value of Digital Health:  Evidence and Impact on Human Health and the Healthcare System,” highlights Medisafe’s leadership position in an industry…

To view the original study, click here. Study rationale and Background Medication nonadherence leads to an estimated 125,000 deaths and costs $100 billion annually in the US. There is a vast pool of tools, including medication adherence apps, which are now available to help patients manage their regimens. However, many of these apps available with…